Aranesp and Panic attacks - a phase IV clinical study of FDA data

Summary:

Panic attacks is reported as a side effect among people who take Aranesp (darbepoetin alfa), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Hydrocortisone, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Panic attacks when taking Aranesp. It is created by eHealthMe based on reports of 54,218 people who have side effects when taking Aranesp from the FDA, and is updated regularly.

What is Aranesp?

Aranesp has active ingredients of darbepoetin alfa. It is often used in anemia. eHealthMe is studying from 54,331 Aranesp users. Check the latest studies of Aranesp.

What is Panic attacks?

Panic attacks is found to be associated with 2,357 drugs and 2,079 conditions by eHealthMe. Check the latest studies of Panic attacks.

On May, 23, 2026

54,218 people reported to have side effects when taking Aranesp.
Among them, 21 people (0.04%) have Panic attacks.

Among these 21 people:

How long have people been on Aranesp when they have Panic attacks? *

What is the gender of people who have Panic attacks when taking Aranesp? *

female: 76.19 %
male: 23.81 %

What is the age of people who have Panic attacks when taking Aranesp? *

What are other drugs people take besides Aranesp? *

Hydrocortisone: 10 people, 47.62%
Percocet: 9 people, 42.86%
Zometa: 9 people, 42.86%
Zoloft: 8 people, 38.10%
Aredia: 8 people, 38.10%
Sodium Bicarbonate: 7 people, 33.33%
Plaquenil: 7 people, 33.33%
Tetracycline Hydrochloride: 7 people, 33.33%
Aricept: 7 people, 33.33%
Keflex: 7 people, 33.33%

What are other side effects people have besides Panic attacks? *

Dyspnea (difficult or laboured breathing): 13 people, 61.90%
Pain: 10 people, 47.62%
Arrhythmias (irregular heartbeat): 10 people, 47.62%
Stress And Anxiety: 10 people, 47.62%
Joint Pain: 10 people, 47.62%
Osteonecrosis Of Jaw (death of bone of jaw): 9 people, 42.86%
Fall: 9 people, 42.86%
Osteomyelitis (infection of bone): 9 people, 42.86%
Hypoaesthesia (reduced sense of touch or sensation): 9 people, 42.86%
Hypotension (abnormally low blood pressure): 9 people, 42.86%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 7 people, 33.33%
Anaemia Of Malignant Disease: 3 people, 14.29%
High Blood Pressure: 2 people, 9.52%
Depression: 2 people, 9.52%
Pulmonary Embolism (blockage of the main artery of the lung): 1 person, 4.76%
Lupus Nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue): 1 person, 4.76%
Herpes Zoster: 1 person, 4.76%
Diabetes: 1 person, 4.76%
Breast Cancer Female: 1 person, 4.76%
Ankylosing Spondylitis (type of arthritis affecting the spine): 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Aranesp and have Panic attacks?

- Check whether Panic attacks is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aranesp:

Aranesp (54,331 reports)

Panic attacks treatments and more:

Panic attacks (65,704 reports)

Browse all side effects of Aranesp:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Panic attacks:

Panic attacks (2,357 drugs)

Browse all the conditions that are associated with Panic attacks:

Panic attacks (2,079 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on darbepoetin alfa (the active ingredients of Aranesp) and Aranesp (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.